RESEARCH
Osteoarthritis: Data Scan Powered by OE M.I.N.D. .
With over 225,000 patients across 530 trials, OrthoEvidence’s M.I.N.D. platform offers an unprecedented lens into global osteoarthritis research. OE M.I.N.D. is used to understand research and reading patterns in osteoarthritis. With data from 530 RCTs involving more than 225,000 patients, the tool shows that knee OA dominates both research activity and reader interest. Hyaluronic acid injections, physical therapy, and exercise are among the most frequently viewed treatments, with orthopaedic surgeons and physiotherapists making up the majority of readers. Most studies report pain using VAS and include a 3-month follow-up. Market analytics also show that major industry contributors—such as Pfizer, Sanofi, Novartis, and Fidia—continue to drive a large portion of OA research.
Already have an account? Log in
Unlock the Full original article
You have access to 4 more FREE articles this month.
Click below to unlock and view this original article
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
